Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, American Medical Association (AMA) President Jesse M. Ehrenfeld, MD, MPH, drew comparisons with the uphill battles physicians are facing today with dwindling reimbursements, physicians shortages, burnout and administrative fights against prior authorization burdens and attempts to preserve access to telehealth. #AMA #AMAHOD24 #AMAHOD2024 #HOD #HOD24 #HOD2024

AMA president calls for physicians to take war-time footing in fight over reimbursement, care quality

Drawing inspiration from the World War II “Why We Fight” campaign that rallied support for the U.S. war effort, AMA President Jesse  Ehrenfeld, MD, spoke on the uphill battles physicians are facing today.

How cardiologists and hospitals get paid via RVUs and DRGs There has been an increasing number of "business of cardiology" sessions are several cardiology conferences over the past two year as reimbursements continue to decline and costs continue to increase. Chief among the topics discussed has been how to navigate the intricacies of how cardiologists and hospitals are reimbursed. One of these speakers was Joel Sauer, MBA, executive vice president of consulting, MedAxiom, who spoke at the American Colle

How cardiologists and hospitals get paid

Joel Sauer, MBA, executive vice president of consulting with MedAxiom, reviews the intricacies of how cardiologists and hospitals are reimbursed.

healthcare money economics dollar stethoscope acquire merger

California bill: Private equity firms must seek AG approval for healthcare buyouts

California Assembly bill AB-3129 requires private equity investors to send an application to the state attorney general 90 days before they purchase a hospital or provider group.

artificial intelligence cybersecurity cybercrime patient data privacy

HHS releases DDoS attack response plan

The Health Sector Cybersecurity Coordination Center's analysis details how healthcare organizations can thwart a botnet invasion.

FDA panel recommends new COVID-19 booster

Booster uptake rates remain low. To date, only 22.5% of Americans received an annual COVID-19 shot from 2023.

artificial intelligence adoption asana anthropic

5 questions to guide the AI voyage from skepticism to maturity across the enterprise

Less than a third of companies employing tech-equipped knowledge workers have a formal AI strategy in place. And “dangerous divides” separate such workers from the leaders to whom they ultimately report.

Moon Surgical gets FDA approval for mission launch of surgery robot

The Maestro robot aids surgeons by holding tools and providing real-time analysis of a surgery.

FDA announces recall of Medtronic brain surgery support systems

Medtronic has issued a recall affecting several versions of its StealthStation S8 due to a software error that puts patients at risk of serious injury or death.

Displaying 409 - 416 of 8453

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.